Halper Sadeh LLC is investigating whether certain officers and directors of Outset Medical, Inc. breached their fiduciary duties to shareholders. Long-term shareholders of Outset Medical may be eligible to seek corporate governance reforms, financial incentives, or other relief. The law firm is offering to handle claims on a contingent fee basis, meaning no upfront legal costs for shareholders. This investigation could lead to improved company oversight and potential compensation for investors if misconduct is proven.
Gossamer Bio stands out in the biotech sector by generating a Return on Invested Capital (ROIC) of 697.21%, vastly exceeding its Weighted Average Cost of Capital (WACC) of 6.57%. This results in an ROIC to WACC ratio of 106.17, meaning the company cr...
Mercury Systems, a defense technology firm, is expected to exceed its upcoming earnings estimates, driven by increased global defense spending due to geopolitical tensions. The company supports numerous defense programs and contractors, benefiting fr...
ACCO Brands Corporation, known for products like Five Star and Swingline, is showing promising growth despite a recent 3% dip in its stock price over 10 days. The stock has gained about 5.2% over the past month, suggesting positive momentum. Analysts...
Amer Sports reported a strong Q1 2026 with revenue up 32% and adjusted EBITDA rising over 30% to $432 million, prompting an upward revision of its full-year financial guidance. Key brands like Arc'teryx and Salomon drove this growth across all market...
Argenx's stock surged 16.66% following positive Phase III ALKIVIA trial results for its autoimmune drug Vyvgart Hytrulo, showing significant efficacy in treating autoimmune myositis. Analyst firm William Blair reaffirmed an 'Outperform' rating, refle...
